First Look Analysts Research Calls for Wednesday, February 1
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Magna (MGA) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $74 > NeoGenomics (NEO) upgraded to Buy from Hold at Needham; tgt $15 >…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Magna (MGA) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $74
> NeoGenomics (NEO) upgraded to Buy from Hold at Needham; tgt $15
> Primis Financial (FRST) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $14
Downgrades:
> American Electric (AEP) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $99
> Edison (EIX) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $73
> Equitrans Midstream (ETRN) downgraded to Sell from Buy at Goldman; tgt lowered to $6
> Funko (FNKO) downgraded to Sell from Neutral at Goldman; tgt lowered to $8.50
> Hasbro (HAS) downgraded to Neutral from Buy at Goldman; tgt $64
> Taysha Gene Therapies (TSHA) downgraded to Hold from Buy at Jefferies; tgt lowered to $1.50
> Veradigm (MDRX) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $18.50
> WSFS Financial (WSFS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $52
Others:
> Beam Therapeutics (BEAM) initiated with an Overweight at Cantor Fitzgerald; tgt $62
> Editas Medicine (EDIT) initiated with an Overweight at Cantor Fitzgerald; tgt $15
> Intellia Therapeutics (NTLA) initiated with an Overweight at Cantor Fitzgerald; tgt $67
> James Hardie (JHX) initiated with a Buy at Goldman
> Mattel (MAT) assumed with a Buy at Goldman; tgt $26
> Rocket Pharmaceuticals (RCKT) initiated with an Overweight at Morgan Stanley; tgt $45
Contact [email protected] for any questions or corrections.
